Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;26(4):489-491.
doi: 10.3350/cmh.2020.0228. Epub 2020 Sep 24.

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis

Paul Kwo  1 , Deepti Dronamraju  1
Affiliations
Editorial

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis

Paul Kwo et al. Clin Mol Hepatol. 2020 Oct.
No abstract available

Keywords: Antiviral agents; Hepatitis C; Liver cirrhosis; Peritoneal dialysis; Renal insufficiency, Chronic.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Kwo reports grants and personal fees from Abbvie, grants from HCV Target Registries, grants and personal fees from Gilead, grants from BMS, personal fees from Syneos Health, outside the submitted work.

Comment on

References

    1. World Health Organization (WHO) Web Annex B. WHO estimates of the prevalence and incidence of hepatitis C virus infection by WHO region, 2015. WHO web site, < https://apps.who.int/iris/bitstream/handle/10665/277005/WHO-CDS-HIV-18.4...>. Accessed 1 Aug 2020.
    1. Fabrizi F, Verdesca S, Messa P, Martin P. Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis. Dig Dis Sci. 2015;60:3801–3813. - PubMed
    1. Chen YC, Chiou WY, Hung SK, Su YC, Hwang SJ. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan. BMC Nephrol. 2013;14:187. - PMC - PubMed
    1. Fabrizi F, Dixit V, Messa P. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? J Viral Hepat. 2012;19:601–607. - PubMed
    1. Goodkin DA, Bieber B, Gillespie B, Robinson BM, Jadoul M. Hepatitis C infection is very rarely treated among hemodialysis patients. Am J Nephrol. 2013;38:405–412. - PubMed